Virtus LifeSci Biotech Products ETF Rating $58.20 -0.32 (-0.55%) As of 06/20/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.74Holdings in BBP have an aggregate rating of Moderate Buy based on 796 analyst ratings issued in the past year covering 61 companies (99.6% of the portfolio).BBP Aggregate Price Target$58.20High Prediction$58.20Average Prediction$58.20Low Prediction$58.20Holdings in BBP have an aggregate price target of $58.20 and a range of $58.20 to $58.20 covering 61 companies (99.6% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy18 Buy rating(s)Moderate Buy29 Moderate Buy rating(s)Hold14 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 61 BBP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.51%BCRXBioCryst Pharmaceuticals$10.10+1.4%4.1493 of 5 stars2.89$16.56 63.9%92.47%KNSAKiniksa Pharmaceuticals International$28.44+1.8%3.1554 of 5 stars3.00$38.80 36.4%5Insider Trade2.45%BPMCBlueprint Medicines$128.20+0.1%0.9954 of 5 stars2.27$128.06 -0.1%22Analyst DowngradeHigh Trading Volume2.42%ONCBeOne Medicines$247.08-2.3%2.06 of 5 stars3.00$319.00 29.1%6Insider TradeGap Down2.39%ASNDAscendis Pharma A/S$176.90+3.6%2.3812 of 5 stars3.00$220.67 24.7%152.28%BBIOBridgeBio Pharma$41.73+4.3%4.5358 of 5 stars2.92$56.67 35.8%13Analyst ForecastHigh Trading Volume2.27%IMCRImmunocore$31.34-1.1%2.2363 of 5 stars2.55$58.89 87.9%112.22%ALNYAlnylam Pharmaceuticals$309.70-0.8%4.045 of 5 stars2.77$319.58 3.2%26Positive News2.21%ACADACADIA Pharmaceuticals$22.71-1.0%3.651 of 5 stars2.69$26.79 17.9%16High Trading Volume2.17%EXELExelixis$40.37-0.9%4.6231 of 5 stars2.47$39.76 -1.5%19Positive NewsHigh Trading Volume2.14%SWTXSpringWorks Therapeutics$46.96+0.4%1.6311 of 5 stars2.13$52.57 11.9%8Positive NewsHigh Trading Volume2.11%GILDGilead Sciences$108.50+0.5%4.9673 of 5 stars2.78$110.55 1.9%27Positive NewsInsider TradeHigh Trading Volume2.08%SAGESage Therapeutics$9.30+1.9%2.9444 of 5 stars2.00$8.93 -3.9%17Analyst ForecastHigh Trading Volume2.08%ZLABZai Lab$34.55-6.4%2.0857 of 5 stars2.75$47.37 37.1%4Positive News2.07%TGTXTG Therapeutics$36.02+2.4%3.4934 of 5 stars2.80$40.80 13.3%52.07%HALOHalozyme Therapeutics$52.81-0.6%4.8652 of 5 stars2.17$61.90 17.2%12Positive NewsHigh Trading Volume2.03%AXSMAxsome Therapeutics$100.69-2.1%4.7042 of 5 stars3.06$172.33 71.2%16Insider Trade2.03%RYTMRhythm Pharmaceuticals$61.99+0.8%4.0892 of 5 stars3.00$76.62 23.6%13Positive News2.01%TBPHTheravance Biopharma$10.63+0.1%2.5282 of 5 stars2.60$14.50 36.4%5News CoverageAnalyst Upgrade1.98%HRMYHarmony Biosciences$31.89-1.8%4.7106 of 5 stars3.13$53.63 68.2%8Positive NewsShort Interest ↑1.95%ADMAADMA Biologics$17.74-2.2%3.626 of 5 stars3.33$27.67 56.0%3Insider Trade1.93%MIRMMirum Pharmaceuticals$50.34-0.9%3.7027 of 5 stars3.13$65.50 30.1%8Positive News1.87%AMGNAmgen$289.33-0.1%4.3969 of 5 stars2.38$309.22 6.9%24Positive NewsHigh Trading Volume1.83%PTCTPTC Therapeutics$50.20-0.5%4.5582 of 5 stars2.67$65.00 29.5%15Analyst ForecastHigh Trading Volume1.77%INSMInsmed$102.68+3.2%3.4169 of 5 stars3.00$106.80 4.0%17Insider TradeHigh Trading Volume1.75%NBIXNeurocrine Biosciences$126.55-0.6%4.7309 of 5 stars2.86$162.00 28.0%22Positive News1.71%VRTXVertex Pharmaceuticals$440.87-1.7%4.5564 of 5 stars2.55$513.14 16.4%29Positive NewsAnalyst Forecast1.67%ROIVRoivant Sciences$11.45+0.1%2.2513 of 5 stars3.00$17.50 52.8%4Analyst ForecastHigh Trading Volume1.67%BNTXBioNTech$106.53+2.0%2.6303 of 5 stars2.83$137.86 29.4%18Analyst Revision1.64%IONSIonis Pharmaceuticals$37.41+1.1%4.3945 of 5 stars2.68$57.59 53.9%191.64%INCYIncyte$68.46+0.3%4.4743 of 5 stars2.22$74.53 8.9%18Trending News1.60%UTHRUnited Therapeutics$290.75-0.3%4.9863 of 5 stars2.69$393.08 35.2%13Positive NewsHigh Trading Volume1.60%MDGLMadrigal Pharmaceuticals$285.73+1.1%4.1039 of 5 stars2.89$420.63 47.2%9News Coverage1.59%LGNDLigand Pharmaceuticals$114.07-0.5%4.4042 of 5 stars3.00$146.14 28.1%7Positive NewsHigh Trading Volume1.56%IBRXImmunityBio$2.87+1.1%1.9117 of 5 stars3.20$12.25 326.8%51.54%TVTXTravere Therapeutics$14.31-0.7%2.4916 of 5 stars2.87$32.14 124.6%151.53%TARSTarsus Pharmaceuticals$40.65-1.0%1.9228 of 5 stars3.00$66.67 64.0%71.53%BMRNBioMarin Pharmaceutical$55.00-0.4%4.9619 of 5 stars2.74$93.45 69.9%23High Trading Volume1.52%AGIOAgios Pharmaceuticals$34.41-3.1%3.8294 of 5 stars2.71$58.60 70.3%7High Trading Volume1.50%BIIBBiogen$127.04+0.4%4.7951 of 5 stars2.38$188.19 48.1%321.47%LEGNLegend Biotech$34.00-2.6%2.4147 of 5 stars2.91$76.20 124.1%11Positive News1.46%AUPHAurinia Pharmaceuticals$7.77-1.9%3.2648 of 5 stars3.00$11.50 48.0%2News CoveragePositive News1.45%CRSPCRISPR Therapeutics$44.25-0.4%3.2917 of 5 stars2.47$69.53 57.1%17Options Volume1.39%NVAXNovavax$6.41+1.7%4.3987 of 5 stars2.29$17.00 165.2%7Analyst Forecast1.37%RAREUltragenyx Pharmaceutical$37.14-0.6%4.2745 of 5 stars2.93$87.00 134.2%14Positive NewsAnalyst Forecast1.35%DVAXDynavax Technologies$9.99-3.0%4.2202 of 5 stars2.50$24.00 140.2%4Positive NewsHigh Trading Volume1.34%LXRXLexicon Pharmaceuticals$0.75+0.6%2.6387 of 5 stars2.40$3.67 388.9%51.31%ARDXArdelyx$3.56-1.4%4.0689 of 5 stars3.00$10.89 205.9%10Analyst ForecastInsider TradeAnalyst RevisionGap Up1.28%KRYSKrystal Biotech$132.46+0.3%4.4582 of 5 stars3.00$211.13 59.4%9High Trading Volume1.18%REGNRegeneron Pharmaceuticals$509.72-0.8%4.8172 of 5 stars2.85$836.48 64.1%26High Trading Volume1.12%MRNAModerna$25.90+2.0%4.4618 of 5 stars2.04$46.61 80.0%231.08%FOLDAmicus Therapeutics$5.64-1.6%4.0852 of 5 stars2.70$16.22 187.6%10High Trading Volume1.04%APLSApellis Pharmaceuticals$17.69-0.4%4.7023 of 5 stars2.62$40.05 126.4%211.03%PHATPhathom Pharmaceuticals$10.42-4.4%3.7942 of 5 stars3.00$17.50 67.9%60.97%DAWNDay One Biopharmaceuticals$6.32-1.4%1.6712 of 5 stars3.13$30.57 383.7%8Positive News0.86%YMABY-mAbs Therapeutics$4.41-4.8%2.7146 of 5 stars2.82$15.60 253.7%11High Trading Volume0.65%GERNGeron$1.51-2.6%3.1825 of 5 stars2.78$5.06 235.3%90.64%ESPREsperion Therapeutics$1.07-2.7%4.0856 of 5 stars2.80$7.00 554.2%5Analyst ForecastAnalyst Revision0.54%SRPTSarepta Therapeutics$20.08-3.3%4.5331 of 5 stars2.46$67.64 236.9%26Trending NewsAnalyst DowngradeOptions VolumeHigh Trading Volume0.39%IOVAIovance Biotherapeutics$1.98-2.9%4.591 of 5 stars2.50$12.22 517.3%120.31%IRWDIronwood Pharmaceuticals$0.70+0.4%4.3475 of 5 stars2.13$4.78 581.8%8 This page (NYSEARCA:BBP) was last updated on 6/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Biggest Story of My Decade-Long Career in Silicon ValleySteve Jobs' Lost 'Product' Could Save Tesla On July 21st, a revolutionary announcement could transform Tesl...InvestorPlace | Sponsored379 passengers walked away from thisForget OpenAI, ChatGPT, and the $2 trillion chip race… The real story is buried inside a new U.S. patent. E...True Market Insiders | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredTrump Makes Major Crypto AnnouncementTrump's crypto revolution is now fully underway and now, we believe he’s about to deliver on his biggest promi...Crypto 101 Media | SponsoredWar Tensions Are Making Gold Rise to Record HighsIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BBP Stock Free BBP Stock Alerts